Shiheng et al. found that MAGEA11 can be used as a diagnostic and prognostic marker for head and neck squamous cell carcinoma [41], Shina et al. demonstrated that MAGEA11 can promote the proliferation of esophageal squamous cell carcinoma [42], and Shifeng also demonstrated that MAGEA11 can predict renal cell carcinoma risk and survival [19]. Here, MAGEA11 is linked to renal cell carcinoma.